EWTX — EDGEWISE THERAPEUTICS INC

Ownership history in STEMPOINT CAPITAL LP  ·  6 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in EDGEWISE THERAPEUTICS INC (EWTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.54% (2025 Q4)
Avg. % of fund
0.89%
First filed
2024 Q2
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 360,876 +310,876 +621.8% 1.54% $9.0M $24.82
2025 Q1 REDUCED 50,000 -130,255 -72.3% 0.08% $238K $22.00
2025 Q1 ADDED 180,255 +47,549 +35.8% 1.26% $4.0M $22.00
2024 Q4 ADDED 132,706 +112,806 +566.9% 0.88% $3.5M $26.70
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    EWTX price (monthly, adj. close)

Other funds also holding EWTX

As of 2025 Q4 — sorted by position size

Novo Holdings A/S 3Y 7Y 10.31% ORBIMED ADVISORS LLC 3Y 7Y 7.86% Ally Bridge Group (NY) LLC 3Y 6.46% Ally Bridge Group (NY) LLC 3Y 5.04% MPM BioImpact LLC 3Y 4.7% Paradigm Biocapital Advisors LP 3Y 4.14% BRAIDWELL LP 3Y 4.14% Cormorant Asset Management, LP 3Y 7Y 3.77% Siren, L.L.C. 3.35% First Light Asset Management, LLC 3Y 7Y 2.99%
← Back to STEMPOINT CAPITAL LP Holdings